Population-level productivity-adjusted life years lost in individuals with type 2 diabetes in Hong Kong: a life table modelling studyResearch in context

Summary: Background: Type 2 diabetes has become increasingly prevalent in young populations who are in their prime working years. We estimated the population-level productivity-adjusted life years (PALYs) lost in the working-age population with type 2 diabetes in Hong Kong. Methods: We constructed...

Full description

Saved in:
Bibliographic Details
Main Authors: Hongjiang Wu, Haobin Zhou, Chuiguo Huang, Aimin Yang, Eric S.H. Lau, Xinge Zhang, Baoqi Fan, Ronald C.W. Ma, Alice P.S. Kong, Elaine Chow, Wing-Yee So, Juliana N.M. Lui, Juliana C.N. Chan, Andrea O.Y. Luk
Format: Article
Language:English
Published: Elsevier 2025-06-01
Series:The Lancet Regional Health. Western Pacific
Subjects:
Online Access:http://www.sciencedirect.com/science/article/pii/S2666606525001221
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1850225856960528384
author Hongjiang Wu
Haobin Zhou
Chuiguo Huang
Aimin Yang
Eric S.H. Lau
Xinge Zhang
Baoqi Fan
Ronald C.W. Ma
Alice P.S. Kong
Elaine Chow
Wing-Yee So
Juliana N.M. Lui
Juliana C.N. Chan
Andrea O.Y. Luk
author_facet Hongjiang Wu
Haobin Zhou
Chuiguo Huang
Aimin Yang
Eric S.H. Lau
Xinge Zhang
Baoqi Fan
Ronald C.W. Ma
Alice P.S. Kong
Elaine Chow
Wing-Yee So
Juliana N.M. Lui
Juliana C.N. Chan
Andrea O.Y. Luk
author_sort Hongjiang Wu
collection DOAJ
description Summary: Background: Type 2 diabetes has become increasingly prevalent in young populations who are in their prime working years. We estimated the population-level productivity-adjusted life years (PALYs) lost in the working-age population with type 2 diabetes in Hong Kong. Methods: We constructed life tables for individuals aged 20–64 years with type 2 diabetes, with simulated follow-up until retirement at 65 years. We then re-simulated the life tables for the same cohort with the hypothetical assumption that they did not have diabetes, adjusting for differences in mortality rates, labour force participation rates, and productivity. We calculated diabetes-related PALYs lost and assumed the cost of each PALY to be equivalent to the annual gross domestic product (GDP) per worker. Findings: In 2019, 6.3% (n = 139,610) of men and 4.2% of women (n = 117,670) of working age had diagnosed type 2 diabetes in Hong Kong. Over their working lifetime, diabetes was associated with a 17.0% (95% CIs: 16.9%, 17.1%) reduction in PALYs in men and 27.8% (95% CIs: 27.6%, 28.0%) in women, equivalent to 1.0 (95% CIs: 1.0, 1.0) and 1.1 (95% CIs: 1.1, 1.1) PALYs lost per man and woman, respectively. Younger individuals with diabetes experienced greater per-person PALYs lost than older individuals. Men and women aged 20–24 years lost 3.9 (95% CIs: 3.9, 3.9) and 5.0 (95% CIs: 5.0, 5.0) PALYs per person due to diabetes, compared to 0.3 (95% CIs: 0.3, 0.3) PALYs in both sexes aged 60–64 years. The total PALYs lost resulted in a GDP loss of USD 15.3 (95% CIs: 15.2, 15.4) billion in men and USD 14.5 (95% CIs: 14.4, 14.6) billion in women. Interpretation: Type 2 diabetes was associated with substantial reductions in PALYs and indirect economic costs in Hong Kong, with disproportionate impacts on women and younger populations. Targeted interventions are needed to address these disparities and mitigate the dual burden of health and economic consequences of diabetes. Funding: Direct Grant for Research from The Chinese University of Hong Kong.
format Article
id doaj-art-9ff4b829b78a425b9c823acf38a9ce7a
institution OA Journals
issn 2666-6065
language English
publishDate 2025-06-01
publisher Elsevier
record_format Article
series The Lancet Regional Health. Western Pacific
spelling doaj-art-9ff4b829b78a425b9c823acf38a9ce7a2025-08-20T02:05:13ZengElsevierThe Lancet Regional Health. Western Pacific2666-60652025-06-015910158510.1016/j.lanwpc.2025.101585Population-level productivity-adjusted life years lost in individuals with type 2 diabetes in Hong Kong: a life table modelling studyResearch in contextHongjiang Wu0Haobin Zhou1Chuiguo Huang2Aimin Yang3Eric S.H. Lau4Xinge Zhang5Baoqi Fan6Ronald C.W. Ma7Alice P.S. Kong8Elaine Chow9Wing-Yee So10Juliana N.M. Lui11Juliana C.N. Chan12Andrea O.Y. Luk13Department of Medicine and Therapeutics, The Chinese University of Hong Kong, Hong Kong Special Administrative Region, People's Republic of China; Hong Kong Institute of Diabetes and Obesity, The Chinese University of Hong Kong, Hong Kong Special Administrative Region, People's Republic of ChinaThe First School of Clinical Medicine, Guangzhou Medical School, People's Republic of ChinaDepartment of Medicine and Therapeutics, The Chinese University of Hong Kong, Hong Kong Special Administrative Region, People's Republic of ChinaDepartment of Medicine and Therapeutics, The Chinese University of Hong Kong, Hong Kong Special Administrative Region, People's Republic of China; Hong Kong Institute of Diabetes and Obesity, The Chinese University of Hong Kong, Hong Kong Special Administrative Region, People's Republic of ChinaDepartment of Medicine and Therapeutics, The Chinese University of Hong Kong, Hong Kong Special Administrative Region, People's Republic of China; Hong Kong Institute of Diabetes and Obesity, The Chinese University of Hong Kong, Hong Kong Special Administrative Region, People's Republic of ChinaDepartment of Medicine and Therapeutics, The Chinese University of Hong Kong, Hong Kong Special Administrative Region, People's Republic of ChinaDepartment of Medicine and Therapeutics, The Chinese University of Hong Kong, Hong Kong Special Administrative Region, People's Republic of ChinaDepartment of Medicine and Therapeutics, The Chinese University of Hong Kong, Hong Kong Special Administrative Region, People's Republic of China; Hong Kong Institute of Diabetes and Obesity, The Chinese University of Hong Kong, Hong Kong Special Administrative Region, People's Republic of China; Li Ka Shing Institute of Health Sciences, The Chinese University of Hong Kong, Hong Kong Special Administrative Region, People's Republic of ChinaDepartment of Medicine and Therapeutics, The Chinese University of Hong Kong, Hong Kong Special Administrative Region, People's Republic of China; Hong Kong Institute of Diabetes and Obesity, The Chinese University of Hong Kong, Hong Kong Special Administrative Region, People's Republic of China; Li Ka Shing Institute of Health Sciences, The Chinese University of Hong Kong, Hong Kong Special Administrative Region, People's Republic of ChinaDepartment of Medicine and Therapeutics, The Chinese University of Hong Kong, Hong Kong Special Administrative Region, People's Republic of ChinaDepartment of Medicine and Therapeutics, The Chinese University of Hong Kong, Hong Kong Special Administrative Region, People's Republic of China; Hong Kong Hospital Authority, Hong Kong Special Administrative Region, People's Republic of ChinaDepartment of Medicine and Therapeutics, The Chinese University of Hong Kong, Hong Kong Special Administrative Region, People's Republic of China; Hong Kong Institute of Diabetes and Obesity, The Chinese University of Hong Kong, Hong Kong Special Administrative Region, People's Republic of ChinaDepartment of Medicine and Therapeutics, The Chinese University of Hong Kong, Hong Kong Special Administrative Region, People's Republic of China; Hong Kong Institute of Diabetes and Obesity, The Chinese University of Hong Kong, Hong Kong Special Administrative Region, People's Republic of China; Li Ka Shing Institute of Health Sciences, The Chinese University of Hong Kong, Hong Kong Special Administrative Region, People's Republic of ChinaDepartment of Medicine and Therapeutics, The Chinese University of Hong Kong, Hong Kong Special Administrative Region, People's Republic of China; Hong Kong Institute of Diabetes and Obesity, The Chinese University of Hong Kong, Hong Kong Special Administrative Region, People's Republic of China; Li Ka Shing Institute of Health Sciences, The Chinese University of Hong Kong, Hong Kong Special Administrative Region, People's Republic of China; Corresponding author. Department of Medicine and Therapeutics, Prince of Wales Hospital, The Chinese University of Hong Kong, 9/F Lui Che Woo Clinical Sciences Building, Shatin, New Territories, Hong Kong Special Administrative Region, People's Republic of China.Summary: Background: Type 2 diabetes has become increasingly prevalent in young populations who are in their prime working years. We estimated the population-level productivity-adjusted life years (PALYs) lost in the working-age population with type 2 diabetes in Hong Kong. Methods: We constructed life tables for individuals aged 20–64 years with type 2 diabetes, with simulated follow-up until retirement at 65 years. We then re-simulated the life tables for the same cohort with the hypothetical assumption that they did not have diabetes, adjusting for differences in mortality rates, labour force participation rates, and productivity. We calculated diabetes-related PALYs lost and assumed the cost of each PALY to be equivalent to the annual gross domestic product (GDP) per worker. Findings: In 2019, 6.3% (n = 139,610) of men and 4.2% of women (n = 117,670) of working age had diagnosed type 2 diabetes in Hong Kong. Over their working lifetime, diabetes was associated with a 17.0% (95% CIs: 16.9%, 17.1%) reduction in PALYs in men and 27.8% (95% CIs: 27.6%, 28.0%) in women, equivalent to 1.0 (95% CIs: 1.0, 1.0) and 1.1 (95% CIs: 1.1, 1.1) PALYs lost per man and woman, respectively. Younger individuals with diabetes experienced greater per-person PALYs lost than older individuals. Men and women aged 20–24 years lost 3.9 (95% CIs: 3.9, 3.9) and 5.0 (95% CIs: 5.0, 5.0) PALYs per person due to diabetes, compared to 0.3 (95% CIs: 0.3, 0.3) PALYs in both sexes aged 60–64 years. The total PALYs lost resulted in a GDP loss of USD 15.3 (95% CIs: 15.2, 15.4) billion in men and USD 14.5 (95% CIs: 14.4, 14.6) billion in women. Interpretation: Type 2 diabetes was associated with substantial reductions in PALYs and indirect economic costs in Hong Kong, with disproportionate impacts on women and younger populations. Targeted interventions are needed to address these disparities and mitigate the dual burden of health and economic consequences of diabetes. Funding: Direct Grant for Research from The Chinese University of Hong Kong.http://www.sciencedirect.com/science/article/pii/S2666606525001221DiabetesProductivity lossLife table
spellingShingle Hongjiang Wu
Haobin Zhou
Chuiguo Huang
Aimin Yang
Eric S.H. Lau
Xinge Zhang
Baoqi Fan
Ronald C.W. Ma
Alice P.S. Kong
Elaine Chow
Wing-Yee So
Juliana N.M. Lui
Juliana C.N. Chan
Andrea O.Y. Luk
Population-level productivity-adjusted life years lost in individuals with type 2 diabetes in Hong Kong: a life table modelling studyResearch in context
The Lancet Regional Health. Western Pacific
Diabetes
Productivity loss
Life table
title Population-level productivity-adjusted life years lost in individuals with type 2 diabetes in Hong Kong: a life table modelling studyResearch in context
title_full Population-level productivity-adjusted life years lost in individuals with type 2 diabetes in Hong Kong: a life table modelling studyResearch in context
title_fullStr Population-level productivity-adjusted life years lost in individuals with type 2 diabetes in Hong Kong: a life table modelling studyResearch in context
title_full_unstemmed Population-level productivity-adjusted life years lost in individuals with type 2 diabetes in Hong Kong: a life table modelling studyResearch in context
title_short Population-level productivity-adjusted life years lost in individuals with type 2 diabetes in Hong Kong: a life table modelling studyResearch in context
title_sort population level productivity adjusted life years lost in individuals with type 2 diabetes in hong kong a life table modelling studyresearch in context
topic Diabetes
Productivity loss
Life table
url http://www.sciencedirect.com/science/article/pii/S2666606525001221
work_keys_str_mv AT hongjiangwu populationlevelproductivityadjustedlifeyearslostinindividualswithtype2diabetesinhongkongalifetablemodellingstudyresearchincontext
AT haobinzhou populationlevelproductivityadjustedlifeyearslostinindividualswithtype2diabetesinhongkongalifetablemodellingstudyresearchincontext
AT chuiguohuang populationlevelproductivityadjustedlifeyearslostinindividualswithtype2diabetesinhongkongalifetablemodellingstudyresearchincontext
AT aiminyang populationlevelproductivityadjustedlifeyearslostinindividualswithtype2diabetesinhongkongalifetablemodellingstudyresearchincontext
AT ericshlau populationlevelproductivityadjustedlifeyearslostinindividualswithtype2diabetesinhongkongalifetablemodellingstudyresearchincontext
AT xingezhang populationlevelproductivityadjustedlifeyearslostinindividualswithtype2diabetesinhongkongalifetablemodellingstudyresearchincontext
AT baoqifan populationlevelproductivityadjustedlifeyearslostinindividualswithtype2diabetesinhongkongalifetablemodellingstudyresearchincontext
AT ronaldcwma populationlevelproductivityadjustedlifeyearslostinindividualswithtype2diabetesinhongkongalifetablemodellingstudyresearchincontext
AT alicepskong populationlevelproductivityadjustedlifeyearslostinindividualswithtype2diabetesinhongkongalifetablemodellingstudyresearchincontext
AT elainechow populationlevelproductivityadjustedlifeyearslostinindividualswithtype2diabetesinhongkongalifetablemodellingstudyresearchincontext
AT wingyeeso populationlevelproductivityadjustedlifeyearslostinindividualswithtype2diabetesinhongkongalifetablemodellingstudyresearchincontext
AT juliananmlui populationlevelproductivityadjustedlifeyearslostinindividualswithtype2diabetesinhongkongalifetablemodellingstudyresearchincontext
AT julianacnchan populationlevelproductivityadjustedlifeyearslostinindividualswithtype2diabetesinhongkongalifetablemodellingstudyresearchincontext
AT andreaoyluk populationlevelproductivityadjustedlifeyearslostinindividualswithtype2diabetesinhongkongalifetablemodellingstudyresearchincontext